Clinical Utility of the Addition of a SNP-based NIPT Zygosity Determination in Twin Pregnancy Management.
NCT ID: NCT05312814
Last Updated: 2024-09-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
137 participants
OBSERVATIONAL
2021-10-01
2023-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Performance of NIPT in Multiple Gestation Pregnancies
NCT04488393
Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies
NCT05004337
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
NCT04595201
Maternal Fetal Device Performance Twins
NCT06835647
National Prevalence and Impact of Noninvasive Prenatal Testing
NCT02284399
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Twin pregnancies undergoing non-invasive prenatal screening
Women carrying a twin pregnancy undergoing non-invasive prenatal screening for zygosity and aneuploidy syndromes.
No drug/device will be administered; clinical data will be collected for research analysis.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
55 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Natera, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ruben Quintero, MD
Role: PRINCIPAL_INVESTIGATOR
The Fetal Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rady Children Specialists of San Diego, San Diego Perinatal Center
San Diego, California, United States
University of Colorado
Aurora, Colorado, United States
Anne Arundel Medical Center/Luminis Health
Annapolis, Maryland, United States
Mayo Clinic
Rochester, Minnesota, United States
Carnegie Imaging for Women
New York, New York, United States
University of Rochester
Rochester, New York, United States
UNC Chapel Hill
Chapel Hill, North Carolina, United States
Seven Hills/ Axia
Cincinnati, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-051-NPT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.